Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

18F-FDG-PET/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis.

[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2017

Kumagai Takuma, Satoh Yoko, Koshiishi Megumi, Ooishi Saori, Sueki Yuki, Nakajima Kei, Mitsumori Toru, Kirito Keita

Abstract excerpt

Although myelofibrosis is mainly associated with myeloproliferative neoplasms (MPN), especially primary myelofibrosis (PMF), a variety of hematological malignancies, including acute myeloid leukemia, multiple myeloma and malignant lymphoma, also cause myelofibrosis with markedly varying degrees of severity. Thus, it is extremely important to accurately diagnose the underlying diseases that cause fibrosis in bone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Bone Marrow

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnosis, Differential

Share to Fluorodeoxyglucose F18

Share to Lymphoma, Large B-Cell, Diffuse

Share to Mutation

Share to Positron Emission Tomography Computed Tomography

Share to Primary Myelofibrosis

Source

Identifiers

PMID: 28381690
DOI: 10.11406/rinketsu.58.228

Genes

JAK2
MPL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

18F-FDG-PET/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis.PMID 28381690Read ↗

How I Diagnose Primary Myelofibrosis.Semantic proximity Read ↗

An accurate, simple prognostic model consisting of age, JAK2, CALR, and MPL mutation status for patients with primary myelofibrosis.Semantic proximity Read ↗

An inconspicuous pulmonary diffuse large B-cell lymphomaSemantic proximity Read ↗

Primary cardiac CD5-positive diffuse large B-cell lymphoma:A case report and review of literatureSemantic proximity Read ↗

Important Pathologic Considerations for Establishing the Diagnosis of Myelofibrosis.Semantic proximity Read ↗

CD56-positive diffuse large B-cell lymphoma/leukemia with BCL6/MYC double-hit and multiple gene mutations: an indicator of poor prognosis?Semantic proximity Read ↗

Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum.Semantic proximity Read ↗

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Semantic proximity Read ↗

Calreticulin mutated prefibrotic-stage myelofibrosis and PMF represent an independent clone from coexisting CLL.Semantic proximity Read ↗

Programmed Death-Ligand 1 (PD-L1) Expression in Patients with Primary or Secondary MyelofibrosisSemantic proximity Read ↗

Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases.Semantic proximity Read ↗

Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.